New weight loss drug CMS-D008 enters first human tests
NCT ID NCT07518589
First seen Apr 10, 2026 · Last updated May 15, 2026 · Updated 7 times
Summary
This early-stage study tests a new drug, CMS-D008, in healthy and overweight adults to see if it is safe and how the body processes it. About 110 participants will receive either the drug or a placebo through injections. The goal is to gather initial safety data, not to prove weight loss yet.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for EVALUATE THE SAFETY AND TOLERABILITY are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.